Your browser doesn't support javascript.
loading
Pulse Dosing of 10-kHz Paresthesia-Independent Spinal Cord Stimulation Provides the Same Efficacy with Substantial Reduction of Device Recharge Time.
Provenzano, David; Tate, Jordan; Gupta, Mayank; Yu, Cong; Verrills, Paul; Guirguis, Maged; Harrison, Nathan; Smith, Thomas; Azalde, Rose; Bradley, Kerry.
Afiliación
  • Provenzano D; Pain Diagnostics & Interventional Care, Sewickley, Pennsylvania, USA.
  • Tate J; Alliance Spine & Pain Centers, Atlanta, Georgia, USA.
  • Gupta M; Neuroscience Research Center, Overland Park, Kansas, USA.
  • Yu C; Swedish Medical Center, Seattle, Washington, USA.
  • Verrills P; Metro Pain Group, Clayton, VIC, Australia.
  • Guirguis M; Ochsner Medical Center, New Orleans, Louisiana, USA.
  • Harrison N; Ochsner Medical Center, New Orleans, Louisiana, USA.
  • Smith T; Guy's and St. Thomas' Hospital NHS Trust, London, UK.
  • Azalde R; Nevro Corporation, Redwood City, California, USA.
  • Bradley K; Nevro Corporation, Redwood City, California, USA.
Pain Med ; 23(1): 152-163, 2022 01 03.
Article en En | MEDLINE | ID: mdl-34601597
ABSTRACT

OBJECTIVE:

This study was designed to assess whether using pulse dosing (PD) (regularly cycled intermittent stimulation) of high-frequency 10-kHz spinal cord stimulation (10-kHz SCS) can reduce device recharge time while maintaining efficacy in patients with chronic intractable back pain with or without leg pain.

DESIGN:

Prospective, multicenter, observational study.

METHODS:

Patients successfully using 10-kHz SCS at 100%ON (i.e., continuously with no PD) for >3 months were consecutively enrolled. After a 1-week baseline period of documenting their pain twice daily on a 0-10 numerical rating scale (NRS) using 100%ON of their "favorite" program, all subjects were reprogrammed to 14%PD for 10-14 days. If subjects preferred 14%PD to 100%ON, they were programmed to 3%PD; otherwise, they were programmed to 50%PD. Subjects used this next program for another 10-14 days. Subjects then entered a 3-month observational period during which they were requested to use but not limited to their most preferred %PD program. Toward the end of 3 months, subjects completed a 7-day NRS diary and indicated a final %PD program preference. Study endpoints included %PD preference, mean diary NRS by %PD, and daily minutes and patterns of charging.

RESULTS:

Of 31 subjects completing the study, 81% preferred less than 100%ON. Among the subjects, 39% preferred 3%PD, 32% preferred 14%PD, 10% preferred 50%PD, and 19% preferred 100%ON. Average daily charge durations were 8.3 ± 3.1 minutes for 3%PD, 13.9 ± 4.9 minutes for 14%PD, 26.2 ± 7.4 minutes for 50%PD, and 43.8 ± 10.9 minutes for 100%ON. Regression modeling suggested that pain relief was weighted as more than twice as influential as charging in preference for reduced %PD.

CONCLUSIONS:

This prospective study suggests that 10-kHz SCS therapy with PD may be successfully used in a large majority of 10-kHz SCS responders, maintaining efficacy while reducing device charging time by nearly two thirds.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dolor Crónico / Estimulación de la Médula Espinal Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Pain Med Asunto de la revista: NEUROLOGIA / PSICOFISIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dolor Crónico / Estimulación de la Médula Espinal Tipo de estudio: Clinical_trials / Observational_studies Límite: Humans Idioma: En Revista: Pain Med Asunto de la revista: NEUROLOGIA / PSICOFISIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos